NRX Pharmaceuticals, Inc.NN

NRX Pharmaceuticals, Inc.

2.07USDR
+0.06+2.99%
At close at Mar 26, 23:37 GMT
USD
No trades
See on Supercharts
Back

Operating expenses (excl. COGS) of NRX Pharmaceuticals, Inc.

Annual data
2018
2019
2020
2021
2022
2023
2024
TTM
‪‪−100.00 M‬‬
‪‪−75.00 M‬‬
‪‪−50.00 M‬‬
‪‪−25.00 M‬‬
‪0.00‬
Period
Value
Change
Change %
TTM
‪‪−19.70 M‬‬
‪0.00‬
‪0.00‬%
2024
‪‪−19.70 M‬‬
+‪‪7.88 M‬‬
+‪28.58‬%
2023
‪‪−27.58 M‬‬
+‪‪16.75 M‬‬
+‪37.78‬%
2022
‪‪−44.33 M‬‬
+‪‪50.87 M‬‬
+‪53.43‬%
2021
‪‪−95.20 M‬‬
‪‪−73.14 M‬‬
‪−331.57‬%
2020
‪‪−22.06 M‬‬
‪‪−22.06 M‬‬
2019
2018
Quarterly data
Q4 '17
Q1 '18
Q2 '18
Q3 '18
Q4 '18
Q1 '19
Q2 '19
Q3 '19
Q4 '19
Q1 '20
Q2 '20
Q3 '20
Q4 '20
Q1 '21
Q2 '21
Q3 '21
Q4 '21
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
‪‪−10.00 M‬‬
‪‪−7.50 M‬‬
‪‪−5.00 M‬‬
‪‪−2.50 M‬‬
‪0.00‬
Period
Value
Change
Change %
Q4 '24
‪‪−3.63 M‬‬
‪‪−613.00 K‬‬
‪−20.30‬%
Q3 '24
‪‪−3.02 M‬‬
+‪‪4.03 M‬‬
+‪57.16‬%
Q2 '24
‪‪−7.05 M‬‬
‪‪−1.05 M‬‬
‪−17.54‬%
Q1 '24
‪‪−6.00 M‬‬
‪‪−1.59 M‬‬
‪−36.14‬%
Q4 '23
‪‪−4.41 M‬‬
+‪‪1.40 M‬‬
+‪24.13‬%
Q3 '23
‪‪−5.81 M‬‬
+‪‪2.13 M‬‬
+‪26.85‬%
Q2 '23
‪‪−7.94 M‬‬
+‪‪1.50 M‬‬
+‪15.87‬%
Q1 '23
‪‪−9.43 M‬‬
+‪‪453.00 K‬‬
+‪4.58‬%
Q4 '22
Q3 '22
Q2 '22
Q1 '22
Q4 '21
Q3 '21
Q2 '21
Q1 '21
Q4 '20
Q3 '20
Q2 '20
Q1 '20
Q4 '19
Q3 '19
Q2 '19
Q1 '19
Q4 '18
Q3 '18
Q2 '18
Q1 '18
Q4 '17